Increased urinary phosphate excretion in pseudohypoparathyroidism type II with long-term treatment with phosphodiesterase inhibitor

Hormone and Metabolic Research

Volumn 31, Issue 11, 1999, Pages 602-605

  Mano, T ^a   Uchimura, K ^a   Hayashi, R ^a   Kobahashi, T ^a   Fujiwara, K ^a   Makino, M ^a   Kakizawa, H ^a   Nagata, M ^a   Nakai, A ^a   Wada, M ^b   Nagasaka, Akio ^a   Itoh, M ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Wada Hospital   (Japan)

Author keywords

CAMP; Phosphodiesterase Inhibitor; Pseudohypoparathyroidism type II

Indexed keywords

CYCLIC AMP; PARATHYROID HORMONE; PHOSPHODIESTERASE INHIBITOR; THEOPHYLLINE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CONSTIPATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HUMAN; HYPOCALCEMIA; IMMUNOREACTIVITY; KIDNEY TUBULE ABSORPTION; PHOSPHATE DEFICIENCY; PRIORITY JOURNAL; PSEUDOHYPOPARATHYROIDISM; URINARY EXCRETION;

EID: 0032751520     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-978804     Document Type: Article

References (18)

1. Albright F, Burnett CH, Smith PH, Parson W. Pseudohypoparathyroidism - An example of "Seabright-Bantam Syndrome". Endocrinology 1942; 30: 922-932
2. 2+ channels in renal epithelial cells by parathyroid hormone. Nature 1990; 347: 388-391
3. Barret D, Breslau NA, Wax MB, Molinoff PB, Downs RW Jr. New form of pseudohypoparathyroidism with abnormal catalytic adenylate cyclase. Am J Physiol 1989; 257: E277-E283
4. Chase LR, Melson GL, Aurbach GH. Pseudohypoparathyroidism: Defective excretion of 3′-5′-AMP in response to parathrymid hormone. J Clin Invest 1969; 48: 1832-1844
5. Drenzner M, Neelson FA, Lebovitz HE, Pseudohypoparathyroidism type II: A possible defect in the reception of the cyclic AMP signal. N Engl J Med 1973; 289: 1056-1060
6. Ellsworth R, Howard JE. Studies on the physiology of the parathyroid glands. Bull Johns Hopkins Hosp 1934; 55: 291-308
7. Henion WF, Sutherland EW, Posternak TH. Effects of derivatives of adenosine 3′,5′-phosphate on liver slices and intact animals. Biochim Biophys Acta 1967; 148: 106-113
8. Klein DC, Berg GR. Pineal gland: Stimulation of metabolism production by norepinephrine involves cyclic AMP-mediated stimulation of N-acetyltransferase. Adv Biochem Psychopharmacol 1970; 3: 241-263
9. Lewin IG, Papapoulos SE, Tomlison S, Hendy GN, O'Riordan JL Studies of hypoparathyroidism and pseudohypoparathyroidism. Quarterly J Meal 1978; 47: 533-548
10. 2+ entry pathways. J Membrane Biol 1991; 123: 161-170
11. Moberg E, Enoksson S, Hagström-Toft E. Importance of phosphodiesterase 3 for the lipolytic response in adipose tissue during insulin-induced hypoglycemia in normal man. Horm Metab Res 1998; 30: 684-688
12. Nishio Y, Kashiwagi A, Takahara N, Hidata H, Kikkawa R. Cilostazol, a cAMP phosphodiesterase inhibitor, attenuates the production of monocyte chemoattractant protein-1 in response to tumor necrosis factor-α in vascular endothelial cells. Horm Metab Res 1997; 29: 491-495
13. Ogata E, Yamamoto M, Matsumoto T, Fujita T, Fukase M, Kinosita Y, Furukawa Y, Sohn HE, Nakajima H, Yasuda T. Standard procedure and the diagnostic criteria for the Ellsworth-Howard test using human PTH(1-34). Folia Endocrinol Jap 1984; 60: 971-984
14. Rao DS, Parfitt AM, Kleerekoper M, Pumo BS, Frame B. Dissociation between the effects of endogenous parathyroid hormone on adenosine 3′,5′-monophosphate generation and phosphate reabsorption in hypocalcemia due to vitamin D depletion: An acquired disorder resembling pseudohypoparathyroidism type II. J Clin Endocrinol Metab 1985; 61: 285-290
15. Rodriguez HJ, Villarneal Jr H, Klahr S, Slatopolsky E. Pseudohypoparathyroidism type II: Restoration of normal renal responsiveness to parathyroid hormone by calcium administration. J Clin Endocrinol Metab 1974; 39: 693-701
16. Silve C, Santora A, Breslau N, Moses A, Spiegel A. Selective resistance to parathyroid hormone in cultured skin fibroblasts from patients with pseudohypoparathyroidism type lb. J Clin Endocrinol Metab 1986; 62: 640-644
17. Suh SM, Fraiser D, Kooh SW. Pseudohypoparathyroidism: Responsiveness to parathyroid extract induced by vitamin D2 therapy. J Clin Endocrinol Metab 1970; 30: 609-614
18. Yamamoto M, Furukawa Y, Tamura Y, Seino Y, Igarashi Y, Fujita T, Ogata E, Imura H. Diagnostic criteria for pseudohypoparathyroidism and related diseases. Folia Endocrinol Jap 1982; 58: 1080-1094